20.07.2020 – 17:12 Davide Molho, DVM Joins Viroclinics Biosciences as Chief Executive Officer Rotterdam, Netherlands (ots/PRNewswire) - Viroclinics Biosciences B.V. ("Viroclinics") today announced the appointment of life sciences industry veteran Davide Molho, DVM as the company's new Chief Executive Officer. Dr. Molho succeeds Bob van Gemen, PhD who has served as the company's CEO since 2011. This transition is part of a planned succession strategy. Dr. ... mehr
03.03.2020 – 14:01 Viroclinics Biosciences and DDL Diagnostic Laboratory Join Forces Rotterdam, Netherlands (ots/PRNewswire) - Two leading virology testing laboratories integrate to form new group serving global biopharmaceutical industry Viroclinics Biosciences, a leading virology contract research organization, announced today that it has acquired DDL Diagnostic Laboratory, a leading diagnostic solutions provider. The transaction enhances the combined group's leading global position in anti-viral and ... mehr